John Carroll University

Carroll Collected
Senior Honors Projects

Theses, Essays, and Senior Honors Projects

Spring 2015

Alkaloid-based chemical defenses in the Brazilian
poison frog Melanophryniscus simplex inhibit
mycobacterial growth
Megan A. Boyk
John Carroll University, mboyk15@jcu.edu

Follow this and additional works at: http://collected.jcu.edu/honorspapers
Part of the Biology Commons
Recommended Citation
Boyk, Megan A., "Alkaloid-based chemical defenses in the Brazilian poison frog Melanophryniscus simplex inhibit mycobacterial
growth" (2015). Senior Honors Projects. 82.
http://collected.jcu.edu/honorspapers/82

This Honors Paper/Project is brought to you for free and open access by the Theses, Essays, and Senior Honors Projects at Carroll Collected. It has
been accepted for inclusion in Senior Honors Projects by an authorized administrator of Carroll Collected. For more information, please contact
connell@jcu.edu.

Alkaloid-based chemical defenses in the Brazilian poison frog Melanophryniscus simplex
inhibit mycobacterial growth
Megan A. Boyk
Senior Honors Project
Spring 2015

Introduction
Throughout evolutionary history, the process of natural selection has resulted in a remarkable
diversity of defensive adaptations that help organisms deter or avoid predation. One such
adaptation is chemical defenses. Organisms that use chemical defenses possess unpalatable or
toxic compounds that discourage attack from potential predators. While most species synthesize
their own chemical defenses, some sequester compounds from their diet (Saporito et al. 2012;
Savitzky et al. 2012). For instance, certain organisms acquire toxins from their food and store
them within their tissues, typically in specialized structures such as glands or spines (Saporito et
al. 2012; Savitzky et al. 2012). A variety of organisms have the ability to sequester chemical
defenses, including arthropods, snakes, and birds, but this mechanism has been best studied in
amphibians, specifically poison frogs (Daly et al. 1994; Saporito et al. 2012; Savitzky et al.
2012).
Poison frogs in the families Dendrobatidae, Bufonidae, Mantellidae, Myobatrachidae,
and Eleutherodactylidae sequester lipophilic alkaloids from a diet of arthropods such as mites,
ants, beetles, and millipedes (for review, see Saporito et al. 2009). Many types of alkaloids have
been identified in poison frog species, which include over 850 unique alkaloid compounds
categorized into more than 20 structural classes. In general, arthropods possess different types
and classes of alkaloids, so the specific set of alkaloids sequestered by an individual frog varies
based on the arthropods in each frog’s diet. As such, there is significant variation in the types
and quantities of alkaloids between individual frogs based on their sex, age, and other
characteristics (Saporito et al. 2009, 2012). Furthermore, alkaloid composition varies among
populations of frogs, and several studies have shown that frog populations from geographically
close locations have similar alkaloid profiles while more distant populations have greater
differences in alkaloid composition (Daly et. al 1994; Saporito et al. 2007; Saporito et al. 2012;
Stuckert et al. 2014; Mina et al. 2015).
In addition to serving as a chemical defense from predators, recent research has shown
that alkaloids may defend poison frogs against infection from microorganisms (MacFoy et al.
2005; Mina et al. 2015). Frogs have moist skin and often live in environments that are ideal for
the growth of potentially pathogenic microbes, such as decaying leaf-litter, rotting logs, or slow
moving-bodies of water (Pough et al. 2003). These conditions would presumably make frogs
highly susceptible to infection; however, frogs appear to have some defenses that are effective
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against microbes (Daly et al. 1987; Clarke 1996). Frog skin secretions contain a wide variety of
biologically active chemicals, including proteins, peptides, steroids, and alkaloids (Daly et al.
1987; Daly et al. 2005; Macfoy et al. 2005). Some of these – especially peptides, which are
manufactured de novo by various frog species – have been found to possess significant
antimicrobial properties (Bevins and Zasloff 1990; Clarke 1996; Rinaldi 2002).
More recently, researchers have determined that individual alkaloids such as
pumiliotoxins and indolizidines found in dendrobatids and other poison frogs are effective
antimicrobial agents against the bacteria Bacillus subtilis and Escherischia coli as well as the
fungus Candida albicans (Macfoy et al. 2005). During the last few years, researchers have
begun to examine the antimicrobial effects of alkaloid cocktails, using the entire complement of
alkaloids extracted from a frog, rather purified individual alkaloids. Alkaloid cocktails from
geographically isolated populations of the dendrobatid frog Oophaga pumilio and the bufonid
toad Melanophryniscus simplex were found to inhibit the growth of B. subtilius, E. coli, and C.
albicans to varying degrees (Gronemeyer 2013; Mina et al. 2015). Gronemeyer (2013) reported
that the alkaloid cocktails in M. simplex, which had greater alkaloid diversity (i.e., more types of
alkaloids) than that of O. pumilio were more effective at inhibiting microbial growth. This may
indicate that alkaloids have a synergistic effect; that is, greater alkaloid diversity results in
greater microbial growth inhibition (Gronemeyer 2013). Mina et al. (2015) tested alkaloids from
five populations of O. pumilio against the same microbes and found that each population
inhibited growth of E. coli and B. subtilis, while only one population inhibited the growth of C.
albicans. This suggests that there are differences in inhibition among frog populations and
between microbe species.
Melanophryniscus simplex, commonly known as the red-belly toad, is a Brazilian poison
frog. Recent research has shown that the red-belly toad possesses alkaloids not only in its skin,
but also in muscle, liver, and mature oocytes (Grant et al. 2012). This discovery supports the
hypothesis that alkaloids play a role in “help[ing] prevent or suppress infection by non-skin
penetrating parasites” (Grant et al. 2012). Sixteen different classes of alkaloids have been
detected in M. simplex skins, and each individual frog has an average of 38 unique alkaloid
compounds (Daly et al. 2007; Daly et al. 2008; Grant et al. 2012). This represents a relatively
diverse alkaloid cocktail, which may result in greater antimicrobial effects. The goals of the
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present study were to test the effectiveness of alkaloid cocktails from six geographically isolated
populations of M. simplex against two bacteria in the genus Mycobacterium.
The genus Mycobacterium is comprised of over 150 species of Gram-positive bacteria,
most of which are harmless and commonly found in the environment (Balazova et al. 2014).
However, some species of Mycobacterium are pathogenic in humans and other animals. For
example, M. tuberculosis and M. leprae cause tuberculosis and leprosy (respectively) in humans.
Additionally, M. bovis and M. avium cause disease in cattle and other mammals (Rue-Albrecht et
al. 2014). Several species have also been known to cause infection in frogs, including M.
marinum, M. ulcerans, and M. lifelandii (Haridy et al. 2014; Tobias et al. 2013; Suykerbuyk et
al. 2007). Several previous studies support the idea that some alkaloids from other sources –
plants, sponges, and tunicates – are effective antimycobacterial agents (Houghton et al. 1998;
Arai et al. 2014; Sureram et al. 2012; Appleton et al. 2010); however, it is not known if alkaloids
from frog skins could provide protection against mycobacteria.
This study investigated the antimycobacterial properties of M. simplex alkaloids from
geographically isolated populations against two species of mycobacteria, M. smegmatis, a soildwelling species, and M. phlei, a saprophytic species (Berney et al. 2014; Egamberdieva 2011).
Both of these species are fast-growing, commonly found in the environment, and typically
nonpathogenic in healthy animals (Balazova et al. 2014, Berney et al. 2014, Egamberdieva
2011). Both M. smegmatis and M. phlei are commonly used as model strains for the study of
antimycobacterial agents (Zhang et al. 2014, Bruce-Micah et al. 2009). Optical density and
colony-forming unit assays were used to evaluate the antimycobacterial effect of these alkaloids.
Optical density was used as a measure of growth inhibition, i.e. the alkaloids’ ability to prevent
the bacteria from growing. Colony-forming unit assays were used to measure the decrease in
viability of the bacteria, i.e. the alkaloids’ ability to kill the bacteria. Ultimately, this study will
provide useful information regarding the role alkaloids play in the microbial defense of poison
frogs, especially against mycobacterial pathogens in M. simplex.

Methods
Frog samples. In this study, alkaloids were extracted from M. simplex skins preserved in
methanol. Alkaloid cocktails were isolated from 18 individual frogs from 6 geographically
isolated Brazilian populations (Figure 1). The frogs used in the present study were a part of a
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larger study aimed at understanding the link between alkaloid variation and arthropod diet
among populations of M. simplex (see Grant et al. 2012). Three frogs were randomly selected
from each of the six populations, and represent a sub-sample of the original collection of M.
simplex.

Alkaloid fractionation. The method of alkaloid fractionation was described in Saporito et al.
2009 and Grant et al. 2012. Each frog skin was preserved in 4 mL of methanol in a glass vial
with a Teflon-lined ® cap (methanol-skin solution). First, 1 mL of the methanol-skin solution
was added to a conical glass vial with 50 µL of HCl. After mixing, each sample was
concentrated with nitrogen gas to a volume of 100 µL. Next, 200 µL of water was added to the
sample. The sample was then extracted four times with 300 µL portions of hexane, and the
hexane layer was removed. The resulting solution was then basified with saturated NaHCO3 and
tested with pH paper to confirm basicity. Then, three extractions with 300 µL portions of ethyl
acetate were carried out. The ethyl acetate alkaloid layer was removed and dried with anhydrous
Na2SO4. The sample was then concentrated to dryness with nitrogen gas. The remaining pure
alkaloids were suspended 100 µL of methanol and stored at -15°C until use in optical density
assays.

Pilot studies. To determine the optimal growth period for accurate evaluation of inhibition and
lethality, pilot studies were completed for M. smegmatis and M. phlei. Based on previous
research using mycobacteria (Houghton et al. 1998; Arai et al. 2014; Sureram et al. 2012;
Appleton et al. 2010) as well as optical density measurements of the growth of untreated M.
smegmatis and M. phlei, a liquid culture of each bacterium was grown at 37°C with agitation in a
7H9 nutrient broth. The culture was filtered through a 0.5 µm filter. Optical density
measurements of 200 µL samples of the broth were taken every 30 minutes at 620 nm with five
seconds of agitation before each measurement. Growth curves were plotted for each bacterium
over various periods of time, and it was determined that a 48 hour optical density measurement
period would best capture the lag, exponential, stationary, and decline phases of growth for both
bacteria.
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Optical density assay. For both Mycobacterium smegmatis and Mycobacterium phlei, a liquid
culture was grown for 48 hours in a 7H9 nutrient broth at 37°C with agitation. Two hundred
microliters of filtered culture were mixed with either 4.8 µL or 9.6 µL of fractionated alkaloid
samples. These volumes were based upon the findings of Mina et al. (2015), in which 4.8 µL was
shown to be effective against other bacteria as a minimal inhibitory dose. To determine whether
a dose-response relationship existed in comparison to the 4.8 µL treatments, replicates were
treated with 9.6 µL of alkaloid as well. Three replicates were completed for each individual at
each volume. Additionally, three replicates were treated with 4.8 µL and 9.6 µL of methanol
alone to determine whether the methanol in which the alkaloids were suspended had an effect on
the growth of the bacteria. Using a 96-well plate spectrophotometer, optical density
measurements were taken at 620 nm every 30 minutes over 48 hours at 37°C. The plate was
agitated for five seconds prior to each measurement. Based on the normal growth curve of each
bacteria, inhibition in optical density assays was evaluated at the endpoint of the measurements.

Colony-forming unit (CFU) assay. Once the optical density measurements were complete,
dilutions of broth cultures from each treated well were spotted in 10 µL aliquots onto 7H11 agar
plates. The first column was a pure sample from the treated well. From the pure sample, tenfold
dilutions were performed in 7H9 nutrient broth and spotted onto the plates (Figure 2). These
cultures were grown at 37°C for 48 hours. Following the growth period, the colonies were
counted and the number of colony-forming units per milliliter of broth were determined using the
following formula:
  
       


    

Statistical analyses. Mean optical densities and mean colony-forming units were compared
among populations and methanol controls with a one-way Analysis of Variance (ANOVA).
Pair-wise comparisons were analyzed using Tukey post-hoc tests. All statistical analyses were
completed using GraphPad Prism 6.

6

Results
Mycobacterium smegmatis. Optical density assays of M. smegmatis treated with 4.8 µL of
alkaloid (Figure 3A) demonstrated that alkaloids from Site 1 (p-value ≤ 0.001), Site 3 (p-value =
0.002), and Site 6 (p-value = 0.050) inhibited the growth of the bacteria significantly more than
the methanol control. There were no significant differences in inhibition between the alkaloids
from sites 1, 3, and 6 (p-value > 0.05 in all comparisons). Colony-forming unit assays of M.
smegmatis treated with 4.8 µL of alkaloid (Figure 3B) showed that alkaloids from Site 1 (p-value
≤ 0.001), Site 2 (p-value ≤ 0.001), and Site 3 (p-value ≤ 0.001) were significantly more lethal to
the bacteria than the methanol control. There were no significant differences in lethality between
populations 1, 3, and 6 (p-value > 0.05 in all comparisons).
According to optical density assays of M. smegmatis treated with 9.6 µL of alkaloid
(Figure 3C), alkaloids from Site 2 (p-value = 0.014), Site 3 (p-value = 0.002), Site 4 (p-value ≤
0.001), Site 5 (p-value ≤ 0.001), and Site 6 (p-value ≤ 0.001) inhibited bacterial growth
significantly more than the methanol control. Between these populations, there were significant
differences in inhibition between Sites 2 and 6 (p-value = 0.037), Sites 4 and 6 (p-value = 0.003),
and Sites 5 and 6 (p-value = 0.004). Colony-forming unit assays of M. smegmatis treated with
9.6 µL of alkaloid indicated that alkaloids from Site 1 (p-value ≤ 0.001), Site 2 (p-value = 0.011),
Site 3 (p-value ≤ 0.001), and Site 4 (p-value = 0.044) were significantly more lethal to the
bacteria than the methanol control. Among these populations, there were significant differences
in inhibition between Sites 1 and 2 (p-value = 0.021), Sites 1 and 4 (p-value ≤ 0.001), Sites 2 and
3 (p-value = 0.010), and Sites 3 and 4 (p-value ≤ 0.001).

Mycobacterium phlei. Optical density assays of M. phlei treated with 4.8 µL of alkaloid (Figure
4A) showed that alkaloids from Site 1 and Site 3 inhibited the growth of the bacteria
significantly more than the methanol control (p ≤ 0.001 in both cases). There was no statistically
significant difference between the inhibition caused by alkaloids from Site 1 and Site 3 (p-value
= 0.910). The samples treated with alkaloids from Site 5 grew significantly more than those
treated with methanol (p-value ≤ 0.001). However, colony-forming unit assays of M. phlei
treated with 4.8 µL of alkaloid (Figure 4B) indicated no significant differences in lethality
between any population and the methanol control (p-value > 0.05 in all comparisons).
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For optical density assays of M. phlei treated with 9.6 µL of alkaloid (Figure 4C),
samples treated alkaloids from Site 4 grew significantly more than the methanol control (p-value
= 0.019). Colony-forming unit assays of M. phlei treated with 9.6 µL of alkaloid (Figure 4D)
indicated that alkaloids from Site 1 (p-value = 0.025) and Site 3 (p-value = 0.031) were
significantly more lethal to the bacteria than the methanol control. The mean colony-forming
units per milliliter for Site 6 was much lower than that of methanol; however, this difference was
not statistically significant (p-value = 0.093), likely because Site 6 had a relatively smaller
sample size than the rest of the populations due to some of the assays being unreadable or too
numerous to count. There were no significant differences in lethality between Site 1 and Site 3
(p-value = 0.133).

Discussion
This study investigated the hypothesis that alkaloid-based skin secretions protect the poison frog
M. simplex from infection by bacteria in the genus Mycobacterium, some of which are known to
be pathogenic in frogs. Two methods, optical density assays and colony-forming unit assays,
were used to measure the antimycobacterial properties of the alkaloids. The data for M.
smegmatis showed that alkaloids from several populations inhibited growth and were lethal to
the bacteria at 4.8 µL. Nearly all of the populations inhibited growth at 9.6 µL in both optical
density and colony-forming unit assays, demonstrating a dose-response relationship. Further,
there were significant differences in inhibition among populations. The data from M. phlei was
inconsistent and inconclusive, and control trials suggested that the methanol in which the
alkaloids were suspended had a significant effect on bacterial growth, which acted as a
confounding factor. The data from M. smegmatis lends further support to the hypothesis that
certain alkaloid compounds inhibit microbial growth, with variation in inhibition based on
geographic location.
The first method of measuring microbial inhibition, optical density, indicated that
alkaloids inhibit the growth of M. smegmatis. This inhibition varies among populations and
exhibits a dose-response relationship. When M. smegmatis was treated with 4.8 µL of alkaloid,
the optical density indicated that three populations (Sites 1, 3, and 6) inhibited microbial growth
significantly more than the methanol control. When the volume of alkaloid was increased to 9.6
µL, five of the six populations inhibited bacterial growth significantly more than the methanol
8

control. Though not statistically significant, there was some degree of inhibition in Site 1
(though this specific test was likely confounded by an outlier frog with less alkaloid diversity
and richness).1 The fact that more populations were inhibitory at 9.6 µL than at 4.8 µL suggests a
dose-response relationship, which is consistent with microbial inhibition. Further, there were
significant differences in inhibition among several populations, supporting the idea that
differences in alkaloid composition as a result of geographic isolation results in differential
microbial inhibition.
On the other hand, the optical density results for M. phlei were inconsistent, with
alkaloids from some populations (Site 1 and Site 3) inhibiting growth at 4.8 µL, but without
significant inhibition at 9.6 µL. Further, cultures treated with alkaloids from two populations
(Site 5 at 4.8 µL and Site 4 at 9.6 µL) grew significantly more than the methanol control.
Clearly, there are some discrepancies in these results. However, the growth curve of M. phlei
treated with methanol alone suggests that the methanol in which the alkaloids were suspended
had a significant effect on M. phlei, which was not seen in M. smegmatis. As a result, it is
impossible to determine the effect caused by the alkaloids alone based on this study. For studies
in which alkaloids are suspended in methanol, it is likely that M. phlei is not a good model for
mycobacterial growth inhibition due to the methanol acting as a confounding factor. Further
research should fully investigate the effect of methanol on this particular bacterial species.
The second method of analysis, colony-forming unit assays, also demonstrated inhibition
of M. smegmatis, which was consistent with the optical density results for this microbe. The
alkaloids collected from Sites 1, 2, and 3 were lethal to M. smegmatis at 4.8 µL. At this volume,
only alkaloids from Sites 1 and 3 inhibited growth of the bacteria in the optical density assay, but

1

Although the mean endpoint optical density was approximately equal to that of the other
populations and lower than that of methanol (Figure 3C), the inhibition was not statistically
significant when compared to the methanol control (p-value = 0.07). However, the cultures
treated with alkaloids from one particular frog from Site 1 had an unusually high optical density
at both 4.8 µL and 9.6 µL. Because there is variation in the alkaloids of individuals from the
same population (Saporito et al. 2012), it is suspected that this individual had a less diverse
alkaloid composition or lower quantities of alkaloids, which may have resulted in lower
inhibition. The presence of an outlier increases the standard error and reduces the ability to
detect a statistical significant difference. The fact that the alkaloids collected from Site 1 were
inhibitory or lethal to M. smegmatis in all other analyses (optical density at 4.8 µL, colonyforming units at 4.8 µL and 9.6 µL) supports the hypothesis that some frogs from Site 1 are, in
fact, inhibitory, but as an entire site, are confounded by an outlier in this specific test.
9

the alkaloids from Site 2 did not. However, this result is not unusual because optical density
may “[measure] live as well as dead bacterial cell debris” (Pan et al. 2014); therefore, it is
possible that a culture with a high optical density may have low viability as determined by the
colony-forming unit assay. At 9.6 µL, alkaloids from Sites 1, 2, 3, and 4 were found to be lethal
to M. smegmatis, which is consistent with the optical density results that showed that alkaloids
from all sites were inhibitory (although the inhibition of Site 1 was not statistically significant;
see above for further discussion on Site 1). These results also indicate that alkaloids from Sites 5
and 6 inhibited the growth of the bacteria, but were not lethal to the bacteria (i.e., they did not
reduce of the viability of the bacteria). Moreover, at 9.6 µL, there were significant differences in
lethality among populations, lending further support to the hypothesis that difference in alkaloid
composition results in difference in microbial inhibition.
In M. phlei, colony-forming unit assays showed that none of the alkaloids were
significantly more lethal to the methanol at 4.8 µL, and only the alkaloids from Site 1 and Site 3
were more lethal to the bacteria at 9.6 µL. The lack of significant difference in inhibition
between the methanol control and each population, as well as the lack of consistency with the
optical density results for M. phlei, lend further support to the hypothesis that the methanol
vehicle was a confounding factor for the results with this species of mycobacteria. Thus, no
meaningful conclusions can be drawn regarding the alkaloids’ ability to affect the growth or
viability of M. phlei.
The relationship between microbial inhibition and alkaloids cannot be fully described
without an analysis of the specific alkaloid compounds that are most and least effective in terms
of microbial growth inhibition and lethality. Unfortunately, the alkaloids present in the frog
skins of the present study have not yet been characterized. However, previous research has
demonstrated that there are significant differences in alkaloid quantity and diversity between
geographically isolated populations of M. simplex (Grant et al. 2012). Grant et al. (2012) also
reported that pumiliotoxins, 5,8-disubstituted indolizidines, 5,6,8-trisubstituted indolizidines,
3,5-disubstituted pyrrolizidines, and some other izidines are well-distributed among M. simplex
populations in the region represented by the present study. Some of these alkaloid classes, such
as pumiliotoxins and indolizidines, were shown by Macfoy et al. (2005) to inhibit the growth of
Escherischia coli, Bacillus subtilis, and Candida albicans. Based on the results of the present
study, it is likely that the alkaloids collected from frogs in Site 1 and Site 3 have the strongest
10

antimicrobial effects because they were active against M. smegmatis in both assays even at a
lower volume (4.8 µL), compared to Site 5, which showed no inhibitory activity at 4.8 µL. A
future study will need to characterize the specific alkaloid compounds present in the samples
used in the present study to determine which alkaloids serve as the best defense against the
mycobacterial species M. smegmatis.
In conclusion, this is the first study to demonstrate that frog alkaloids from M. simplex
effectively inhibit the growth of bacteria in a genus known to be pathogenic in anurans.
Therefore, if M. smegmatis is a good model for other species of mycobacteria, it is possible that
alkaloids defend this species of poison frog (and possibly others) from infection as well as
predators. As suggested by the variation in inhibition and lethality among populations, the level
of defense from infection likely varies among populations, which is likely based on differences
in the alkaloid profiles of geographically isolated locations. Future research should investigate
microbial growth inhibition and lethality in microbes that are known to be pathogenic to anurans
and that are known to naturally occur in poison frog habitats.
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Figure 1. Map of Melanophryniscus simplex collection locations in Brazil. Note: Sites 5 and 6
are geographically close, but represent distinct collection locations.
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Figure 2. Colony-forming unit (CFU) assay for frog alkaloids tested against Mycobacterium
phlei. Rows 1-3 were treated with 4.8 microliters of alkaloid; rows 4-6 were treated with 9.6
microliters of alkaloid. Column A is a pure culture of M. phlei, followed by a tenfold dilution in
each successive column.
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Figure 3. Optical density and colony-forming unit analyses for Mycobacterium smegmatis.
(A) Mean endpoint optical density measurements for Mycobacterium smegmatis treated with 4.8
microliters of alkaloid. The dotted line represents the level of inhibition by the methanol control.
(B) Mean colony-forming units per mL for Mycobacterium smegmatis treated with 4.8
microliters of alkaloid. (C) Mean endpoint optical density measurements for Mycobacterium
smegmatis treated with 9.6 microliters of alkaloid. The dotted line represents the level of
inhibition by the methanol control. (D) Mean colony-forming units per mL for Mycobacterium
smegmatis treated with 9.6 microliters of alkaloid.
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Figure 4. Optical density and colony-forming unit analyses for Mycobacterium phlei. (A) Mean
endpoint optical density measurements for Mycobacterium phlei treated with 4.8 microliters of
alkaloid. The dotted line represents the level of inhibition by the methanol control. (B) Mean
colony-forming units per mL for Mycobacterium phlei treated with 4.8 microliters of alkaloid.
(C) Mean endpoint optical density measurements for Mycobacterium phlei treated with 9.6
microliters of alkaloid. The dotted line represents the level of inhibition by the methanol control.
(D) Mean colony-forming units per mL for Mycobacterium phlei treated with 9.6 microliters of
alkaloid.
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